EUVIMEDEUVIMED entdecken
Multizentrische StudieÜbersichtsarbeitLeitlinieOpen Access · CC BY-NC-ND 4.0

Invalidity of Tokyo guidelines in acute biliary pancreatitis: A multicenter cohort analysis of 944 pancreatitis cases

Márk Félix Juhász, Rebeka Tóháti, Viktória Adrienn Jászai, Regina Molnár, Nelli Farkas, László Czakó, Áron Vincze, Bálint Erőss, Andrea Szentesi, Ferenc Izbéki, Mária Papp, Péter Hegyi iD und 2 weitere

United European Gastroenterology Journal · 2023-10 · 11 (8) · 767-774

DOI: 10.1002/ueg2.12402 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 18.07.2023. Verfasst von Márk Félix Juhász und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. Hauptthemen laut MEDLINE: Pancreatitis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is a noteworthy overlap between the clinical picture of biliary acute pancreatitis (AP) and the 2018 Tokyo guidelines currently used for the diagnosis of cholangitis (AC) and cholecystitis (CC). This can lead to significant antibiotic and endoscopic retrograde cholangiopancreatography (ERCP) overuse.

Objectives

We aimed to assess the on‐admission prevalence of AC/CC according to the 2018 Tokyo guidelines (TG18) in a cohort of biliary AP patients, and its association with antibiotic use, ERCP and clinically relevant endpoints.

Methods

We conducted a secondary analysis of the Hungarian Pancreatic Study Group's prospective multicenter registry of 2195 AP cases. We grouped and compared biliary cases ( n = 944) based on the on‐admission fulfillment of definite AC/CC according to TG18. Aside from antibiotic use, we evaluated mortality, AC/CC/AP severity, ERCP performance and length of hospitalization. We also conducted a literature review discussing each criteria of the TG18 in the context of AP.

Results

27.8% of biliary AP cases fulfilled TG18 for both AC and CC, 22.5% for CC only and 20.8% for AC only. Antibiotic use was high (77.4%). About 2/3 of the AC/CC cases were mild, around 10% severe. Mortality was below 1% in mild and moderate AC/CC patients, but considerably higher in severe cases (12.8% and 21.2% in AC and CC). ERCP was performed in 89.3% of AC cases, common bile duct stones were found in 41.1%.

Conclusion

Around 70% of biliary AP patients fulfilled the TG18 for AC/CC, associated with a high rate of antibiotic use. Mortality in presumed mild or moderate AC/CC is low. Each of the laboratory and clinical criteria are commonly fulfilled in biliary AP, single imaging findings are also unspecific—AP specific diagnostic criteria are needed, as the prevalence of AC/CC are likely greatly overestimated. Randomized trials testing antibiotic use are also warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatitisHumansAcute DiseaseAnti-Bacterial AgentsProspective StudiesTokyoGuidelines as Topic

Stichwörter der Autor:innen

2018 Tokyo guidelinesERCPantibiotic usebiliary acute pancreatitischolangitischolecystitisendoscopic retrograde cholangiopancreatographymortalitystones

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
  • Heim Pál National Pediatric Institute, Budapest, Hungary.
  • Semmelweis University, Budapest, Hungary.
  • Institute of Bioanalysis, Medical School, University of Pécs, Pécs, Hungary.
  • Department of Medicine, University of Szeged, Szeged, Hungary.
  • Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.

ORCID-Profile: Péter Hegyi, Andrea Párniczky

Zitieren

APA

Juhász, M. F., Tóháti, R., Jászai, V. A., Molnár, R., Farkas, N., Czakó, L., Vincze, Á., Erőss, B., Szentesi, A., Izbéki, F., Papp, M., Hegyi, P., Párniczky, A., & Hungarian Pancreatic Study Group (2023). Invalidity of Tokyo guidelines in acute biliary pancreatitis: A multicenter cohort analysis of 944 pancreatitis cases. United European Gastroenterology Journal, 11(8), 767-774. https://doi.org/10.1002/ueg2.12402

Vancouver

Juhász MF, Tóháti R, Jászai VA, Molnár R, Farkas N, Czakó L, et al. Invalidity of Tokyo guidelines in acute biliary pancreatitis: A multicenter cohort analysis of 944 pancreatitis cases. United European Gastroenterology Journal. 2023;11(8):767-774. doi:10.1002/ueg2.12402

BibTeX
@article{Juhsz2023,
  author = {Juhász, Márk Félix and Tóháti, Rebeka and Jászai, Viktória Adrienn and Molnár, Regina and Farkas, Nelli and Czakó, László and Vincze, Áron and Erőss, Bálint and Szentesi, Andrea and Izbéki, Ferenc and Papp, Mária and Hegyi, Péter and Párniczky, Andrea and Hungarian Pancreatic Study Group, Hungarian Pancreatic Study Group},
  title = {Invalidity of Tokyo guidelines in acute biliary pancreatitis: A multicenter cohort analysis of 944 pancreatitis cases},
  journal = {United European Gastroenterology Journal},
  year = {2023},
  volume = {11},
  number = {8},
  pages = {767--774},
  doi = {10.1002/ueg2.12402}
}
Kostenlos starten →